555 related articles for article (PubMed ID: 11177311)
1. Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.
Tung BY; Emond MJ; Haggitt RC; Bronner MP; Kimmey MB; Kowdley KV; Brentnall TA
Ann Intern Med; 2001 Jan; 134(2):89-95. PubMed ID: 11177311
[TBL] [Abstract][Full Text] [Related]
2. Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study.
Lindberg BU; Broomé U; Persson B
Dis Colon Rectum; 2001 Jan; 44(1):77-85. PubMed ID: 11805567
[TBL] [Abstract][Full Text] [Related]
3. Prevention of colon cancer with ursodiol in ulcerative colitis.
Kim HS
Inflamm Bowel Dis; 2001 Aug; 7(3):279-80. PubMed ID: 11515858
[No Abstract] [Full Text] [Related]
4. Chemoprevention in ulcerative colitis: narrowing the gap between clinical practice and research.
Hawk ET; Viner JL
Ann Intern Med; 2001 Jan; 134(2):158-60. PubMed ID: 11177320
[No Abstract] [Full Text] [Related]
5. Ursodiol for all?
Lee SD; Surawicz CM
Am J Gastroenterol; 2001 Dec; 96(12):3437-8. PubMed ID: 11774966
[No Abstract] [Full Text] [Related]
6. Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis.
Pardi DS; Loftus EV; Kremers WK; Keach J; Lindor KD
Gastroenterology; 2003 Apr; 124(4):889-93. PubMed ID: 12671884
[TBL] [Abstract][Full Text] [Related]
7. The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis.
Wolf JM; Rybicki LA; Lashner BA
Aliment Pharmacol Ther; 2005 Nov; 22(9):783-8. PubMed ID: 16225486
[TBL] [Abstract][Full Text] [Related]
8. Colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.
Gurbuz AK; Giardiello FM; Bayless TM
Dis Colon Rectum; 1995 Jan; 38(1):37-41. PubMed ID: 7813342
[TBL] [Abstract][Full Text] [Related]
9. Ursodeoxycholic acid in patients with ulcerative colitis and primary sclerosing cholangitis for prevention of colon cancer: a meta-analysis.
Ashraf I; Choudhary A; Arif M; Matteson ML; Hammad HT; Puli SR; Bechtold ML
Indian J Gastroenterol; 2012 Apr; 31(2):69-74. PubMed ID: 22528343
[TBL] [Abstract][Full Text] [Related]
10. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U
J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613
[TBL] [Abstract][Full Text] [Related]
11. Random biopsies during surveillance colonoscopy increase dysplasia detection in patients with primary sclerosing cholangitis and ulcerative colitis.
Navaneethan U; Kochhar G; Venkatesh PG; Bennett AE; Rizk M; Shen B; Kiran RP
J Crohns Colitis; 2013 Dec; 7(12):974-81. PubMed ID: 23523416
[TBL] [Abstract][Full Text] [Related]
12. High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.
Eaton JE; Silveira MG; Pardi DS; Sinakos E; Kowdley KV; Luketic VA; Harrison ME; McCashland T; Befeler AS; Harnois D; Jorgensen R; Petz J; Lindor KD
Am J Gastroenterol; 2011 Sep; 106(9):1638-45. PubMed ID: 21556038
[TBL] [Abstract][Full Text] [Related]
13. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis.
Soetikno RM; Lin OS; Heidenreich PA; Young HS; Blackstone MO
Gastrointest Endosc; 2002 Jul; 56(1):48-54. PubMed ID: 12085034
[TBL] [Abstract][Full Text] [Related]
14. Liver involvement in patients operated for ulcerative colitis, with special reference to the association of cholangitis with colorectal dysplasia and carcinoma.
Aitola P; Mattila J; Matikainen M
Int J Colorectal Dis; 2000 Jun; 15(3):167-71. PubMed ID: 10954188
[TBL] [Abstract][Full Text] [Related]
15. Increased risk of colorectal cancer and dysplasia in patients with Crohn's colitis and primary sclerosing cholangitis.
Lindström L; Lapidus A; Ost A; Bergquist A
Dis Colon Rectum; 2011 Nov; 54(11):1392-7. PubMed ID: 21979184
[TBL] [Abstract][Full Text] [Related]
16. Duration and severity of primary sclerosing cholangitis is not associated with risk of neoplastic changes in the colon in patients with ulcerative colitis.
Navaneethan U; Kochhar G; Venkatesh PG; Lewis B; Lashner BA; Remzi FH; Shen B; Kiran RP
Gastrointest Endosc; 2012 May; 75(5):1045-1054.e1. PubMed ID: 22405258
[TBL] [Abstract][Full Text] [Related]
17. Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance.
Navaneethan U; Jegadeesan R; Gutierrez NG; Venkatesh PG; Hammel JP; Shen B; Kiran RP
J Crohns Colitis; 2013 Dec; 7(12):e684-91. PubMed ID: 23916526
[TBL] [Abstract][Full Text] [Related]
18. Dysplasia and colorectal cancer in a patient with ulcerative colitis and primary sclerosing cholangitis: a case report and a short review of the literature.
Chaparro M; Trapero-Marugán M; Guijarro M; López C; Moreno-Otero R; Gisbert JP
J Crohns Colitis; 2013 Mar; 7(2):e61-5. PubMed ID: 22552273
[TBL] [Abstract][Full Text] [Related]
19. Ulcerative colitis and an abnormal cholangiogram.
Nguyen DL; Lazaridis KN
Cleve Clin J Med; 2011 May; 78(5):306-11. PubMed ID: 21536825
[No Abstract] [Full Text] [Related]
20. Combined therapy with azathioprine, prednisolone, and ursodiol in patients with primary sclerosing cholangitis. A case series.
Schramm C; Schirmacher P; Helmreich-Becker I; Gerken G; zum Büschenfelde KH; Lohse AW
Ann Intern Med; 1999 Dec; 131(12):943-6. PubMed ID: 10610645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
